Phase 1 — Early testing in a small group of people (usually 20–80) to evaluate safety, determine safe dosage, and identify side effects.
Trial locations(7 sites)
United States
UC Irvine Chao Family Cancer Centre, Orange, California University of Florida Shands, Gainesville, Florida Icahn School of Medicine at Mount Sinai, New York, New York Cleveland Clinic, Cleveland, Ohio Vanderbilt University Medical Centre, Nashville, Tennessee Australia
GenesisCare, St Leonards, New South Wales Epworth Healthcare, Richmond, Victoria